Insider Trading › ITCI › Insiders
ITCI
ITCI·Insider activity
—
No end-of-day price on record
ITCI
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ITCIS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of ITCI were filed in the last 180 days. Newest filing Dec 6, 2024 (1 year ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by ITCI insiders · Form 4 · last two years
No open-market insider buys or sells in the last two years.
On Record
$0Purchases · 180 days
$0Sales · 180 days
455Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of ITCI common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
455 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Mates SharonChairman and CEO · Director | Sale | −1,534 | $84.69 | $130K | 1.1Mdirect | Dec 5, 2024 | Dec 6, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −50.2K | $84.06 | $4.2M | 1.1Mdirect | Dec 5, 2024 | Dec 6, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −23.3K | $86.00 | $2.0M | 1.1Mdirect | Dec 4, 2024 | Dec 6, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −27.7K | $85.62 | $2.4M | 1.1Mdirect | Dec 4, 2024 | Dec 6, 2024 | Form 4 ↗ |
| Halstead MichaelPresident | Sale | −5,343 | $88.92 | $475K | 0direct | Nov 13, 2024 | Nov 14, 2024 | Form 4 ↗ |
| Halstead MichaelPresident | Sale | −13.4K | $88.17 | $1.2M | 5,343direct | Nov 13, 2024 | Nov 14, 2024 | Form 4 ↗ |
| Halstead MichaelPresident | Sale | −1,648 | $90.89 | $150K | 0direct | Nov 12, 2024 | Nov 14, 2024 | Form 4 ↗ |
| Halstead MichaelPresident | Sale | −6,116 | $89.63 | $548K | 1,648direct | Nov 12, 2024 | Nov 14, 2024 | Form 4 ↗ |
| Halstead MichaelPresident | Sale | −15.1K | $88.72 | $1.3M | 7,764direct | Nov 12, 2024 | Nov 14, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −6,193 | $73.32 | $454K | 1.1Mdirect | Aug 30, 2024 | Aug 30, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −28.2K | $72.73 | $2.1M | 1.1Mdirect | Aug 30, 2024 | Aug 30, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −5,772 | $73.25 | $423K | 1.1Mdirect | Aug 29, 2024 | Aug 30, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −29.8K | $72.44 | $2.2M | 1.1Mdirect | Aug 29, 2024 | Aug 30, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −240 | $73.70 | $18K | 1.1Mdirect | Aug 28, 2024 | Aug 28, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −32.5K | $72.74 | $2.4M | 1.1Mdirect | Aug 28, 2024 | Aug 28, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −16.9K | $73.93 | $1.2M | 1.1Mdirect | Aug 27, 2024 | Aug 28, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −23.7K | $73.33 | $1.7M | 1.1Mdirect | Aug 27, 2024 | Aug 28, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −22.7K | $74.59 | $1.7M | 1.1Mdirect | Aug 26, 2024 | Aug 28, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −28.7K | $74.46 | $2.1M | 1.1Mdirect | Aug 23, 2024 | Aug 23, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −4,369 | $75.47 | $330K | 1.1Mdirect | Aug 22, 2024 | Aug 23, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −35.0K | $74.58 | $2.6M | 1.1Mdirect | Aug 22, 2024 | Aug 23, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −1,900 | $77.98 | $148K | 1.1Mdirect | Aug 21, 2024 | Aug 23, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −2,682 | $77.21 | $207K | 1.1Mdirect | Aug 21, 2024 | Aug 23, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −4,297 | $76.20 | $327K | 1.1Mdirect | Aug 21, 2024 | Aug 23, 2024 | Form 4 ↗ |
| Mates SharonChairman and CEO · Director | Sale | −44.1K | $75.40 | $3.3M | 1.1Mdirect | Aug 21, 2024 | Aug 23, 2024 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −18.7K | $75.08 | $1.4M | 29.7Kdirect | Aug 16, 2024 | Aug 20, 2024 | Form 4 ↗ |
| RIGGS RORY BDirector | Sale | −4,462 | $75.57 | $337K | 116.6Kdirect | Jun 24, 2024 | Jun 25, 2024 | Form 4 ↗ |
| VAN NOSTRAND ROBERT LDirector | Sale | −11.1K | $76.07 | $845K | 9,690direct | Jun 18, 2024 | Jun 21, 2024 | Form 4 ↗ |
| VAN NOSTRAND ROBERT LDirector | Sale | −8,891 | $75.71 | $673K | 20.8Kdirect | Jun 18, 2024 | Jun 21, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −306 | $67.33 | $21K | 1.1Mdirect | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −1,590 | $66.81 | $106K | 1.1Mdirect | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −4,128 | $65.90 | $272K | 1.1Mdirect | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −14.5K | $64.80 | $942K | 1.1Mdirect | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance, CFO | Sale | −64 | $67.12 | $4K | 0direct | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance, CFO | Sale | −4,475 | $66.47 | $297K | 64direct | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance, CFO | Sale | −29 | $67.32 | $2K | 0direct | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance, CFO | Sale | −1,100 | $66.54 | $73K | 29direct | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance, CFO | Sale | −4,453 | $65.28 | $291K | 1,129direct | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −1,238 | $66.70 | $83K | 0direct | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −6,107 | $65.82 | $402K | 1,238direct | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −1,313 | $66.86 | $88K | 29.7Kdirect | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −1,729 | $65.92 | $114K | 31.0Kdirect | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −4,303 | $65.11 | $280K | 32.7Kdirect | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −661 | $66.96 | $44K | 19.8Kdirect | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −872 | $65.89 | $57K | 20.5Kdirect | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −2,179 | $65.06 | $142K | 21.3Kdirect | Mar 11, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −8,754 | $66.93 | $586K | 1.1Mdirect | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −32.0K | $66.38 | $2.1M | 1.1Mdirect | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance, CFO | Sale | −6,618 | $66.93 | $443K | 0direct | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance, CFO | Sale | −6,514 | $66.26 | $432K | 6,618direct | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −220 | $66.81 | $15K | 0direct | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −12.9K | $66.14 | $854K | 220direct | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −4,496 | $66.95 | $301K | 29.7Kdirect | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −8,636 | $66.37 | $573K | 34.2Kdirect | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −2,722 | $66.86 | $182K | 16.2Kdirect | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −3,728 | $66.34 | $247K | 18.9Kdirect | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| VAN NOSTRAND ROBERT LDirector | Sale | −10.3K | $73.14 | $757K | 9,611direct | Feb 27, 2024 | Feb 28, 2024 | Form 4 ↗ |
| VAN NOSTRAND ROBERT LDirector | Sale | −9,651 | $72.71 | $702K | 20.0Kdirect | Feb 27, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −392 | $70.13 | $27K | 0direct | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −7,215 | $69.54 | $502K | 392direct | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −300 | $68.54 | $21K | 7,607direct | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance, CFO | Sale | −600 | $69.81 | $42K | 0direct | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance, CFO | Sale | −5,282 | $69.47 | $367K | 600direct | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance, CFO | Sale | −288 | $70.15 | $20K | 0direct | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance, CFO | Sale | −6,867 | $69.38 | $476K | 288direct | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance, CFO | Sale | −300 | $68.33 | $20K | 7,155direct | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −12.5K | $70.11 | $874K | 1.1Mdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −9,528 | $69.45 | $662K | 1.1Mdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −600 | $68.39 | $41K | 1.1Mdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −1,312 | $71.02 | $93K | 9,488direct | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −1,400 | $70.16 | $98K | 10.8Kdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −1,400 | $69.38 | $97K | 12.2Kdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −1,307 | $71.18 | $93K | 29.7Kdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −2,341 | $70.70 | $166K | 31.0Kdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −4,059 | $69.56 | $282K | 33.3Kdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −200 | $68.03 | $14K | 37.4Kdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| MARCUS JOEL SDirector | Sale | −299 | $69.60 | $21K | 39.7Kdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| MARCUS JOEL SDirector | Sale | −17.7K | $69.07 | $1.2M | 40.0Kdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| MARCUS JOEL SDirector | Sale | −8,371 | $67.83 | $568K | 57.6Kdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −714 | $67.17 | $48K | 0direct | Feb 2, 2024 | Feb 5, 2024 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −11.1K | $66.37 | $740K | 714direct | Feb 2, 2024 | Feb 5, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −17.4K | $67.42 | $1.2M | 1.1Mdirect | Feb 2, 2024 | Feb 5, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −16.4K | $66.70 | $1.1M | 1.1Mdirect | Feb 2, 2024 | Feb 5, 2024 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −6,904 | $67.49 | $466K | 29.7Kdirect | Feb 2, 2024 | Feb 5, 2024 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −4,956 | $66.67 | $330K | 36.6Kdirect | Feb 2, 2024 | Feb 5, 2024 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance, CFO | Sale | −185 | $67.35 | $12K | 0direct | Feb 2, 2024 | Feb 5, 2024 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance, CFO | Sale | −11.0K | $66.61 | $733K | 185direct | Feb 2, 2024 | Feb 5, 2024 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −3,847 | $67.49 | $260K | 5,693direct | Feb 2, 2024 | Feb 5, 2024 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −2,320 | $66.69 | $155K | 9,540direct | Feb 2, 2024 | Feb 5, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −320 | $66.25 | $21K | 1.1Mdirect | Jan 18, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −67.6K | $65.19 | $4.4M | 1.1Mdirect | Jan 18, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −17.5K | $66.66 | $1.2M | 1.1Mdirect | Jan 17, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −30.6K | $66.00 | $2.0M | 1.1Mdirect | Jan 17, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −5,882 | $67.76 | $399K | 1.1Mdirect | Jan 16, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −66.0K | $67.25 | $4.4M | 1.1Mdirect | Jan 16, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −3,500 | $66.38 | $232K | 1.1Mdirect | Jan 16, 2024 | Jan 18, 2024 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −1,486 | $67.80 | $101K | 0direct | Jan 11, 2024 | Jan 12, 2024 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −30.4K | $67.10 | $2.0M | 1,486direct | Jan 11, 2024 | Jan 12, 2024 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −18.2K | $66.31 | $1.2M | 31.8Kdirect | Jan 11, 2024 | Jan 12, 2024 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −2,210 | $71.77 | $159K | 0direct | Jan 2, 2024 | Jan 4, 2024 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −22.6K | $70.80 | $1.6M | 2,210direct | Jan 2, 2024 | Jan 4, 2024 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −37.4K | $70.41 | $2.6M | 24.9Kdirect | Jan 2, 2024 | Jan 4, 2024 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −21.3K | $65.00 | $1.4M | 0direct | Dec 13, 2023 | Dec 15, 2023 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −41.1K | $54.01 | $2.2M | 0direct | Nov 13, 2023 | Nov 14, 2023 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −8,933 | $53.37 | $477K | 41.1Kdirect | Nov 13, 2023 | Nov 14, 2023 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −15.6K | $55.02 | $860K | 29.7Kdirect | Nov 6, 2023 | Nov 8, 2023 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −26.8K | $55.98 | $1.5M | 45.3Kdirect | Nov 6, 2023 | Nov 8, 2023 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −44.4K | $54.17 | $2.4M | 1.1Mdirect | Sep 19, 2023 | Sep 19, 2023 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −28.1K | $53.96 | $1.5M | 1.1Mdirect | Sep 18, 2023 | Sep 19, 2023 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −27.5K | $53.55 | $1.5M | 1.1Mdirect | Sep 18, 2023 | Sep 19, 2023 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −55.3K | $58.79 | $3.3M | 45.3Kdirect | Aug 7, 2023 | Aug 9, 2023 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −1,842 | $65.00 | $120K | 21.3Kdirect | Jul 17, 2023 | Jul 20, 2023 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −3,592 | $65.01 | $234K | 0direct | Jun 14, 2023 | Jun 16, 2023 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −44.0K | $64.37 | $2.8M | 3,592direct | Jun 14, 2023 | Jun 16, 2023 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −34.2K | $63.35 | $2.2M | 47.6Kdirect | Jun 14, 2023 | Jun 16, 2023 | Form 4 ↗ |
| VAN NOSTRAND ROBERT LDirector | Sale | −10.0K | $63.00 | $630K | 9,345direct | Apr 17, 2023 | Apr 19, 2023 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −10.2K | $54.01 | $550K | 45.3Kdirect | Mar 28, 2023 | Mar 30, 2023 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −5,421 | $54.86 | $297K | 55.5Kdirect | Mar 28, 2023 | Mar 30, 2023 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −346 | $44.29 | $15K | 23.1Kdirect | Mar 13, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Durgam Suresh K.EVP, Chief Medical Officer | Sale | −6,998 | $45.08 | $315K | 23.4Kdirect | Mar 13, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −423 | $44.05 | $19K | 60.9Kdirect | Mar 13, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −3,335 | $45.10 | $150K | 61.4Kdirect | Mar 13, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −476 | $44.15 | $21K | 0direct | Mar 13, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −6,868 | $44.99 | $309K | 476direct | Mar 13, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −258 | $44.14 | $11K | 0direct | Mar 13, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −5,324 | $44.97 | $239K | 258direct | Mar 13, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −1,412 | $44.08 | $62K | 1.1Mdirect | Mar 13, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −19.2K | $45.06 | $863K | 1.1Mdirect | Mar 13, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −1,800 | $42.74 | $77K | 57.4Kdirect | Mar 10, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −6,750 | $43.50 | $294K | 59.2Kdirect | Mar 10, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −2,500 | $42.52 | $106K | 0direct | Mar 10, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −14.2K | $43.20 | $614K | 2,500direct | Mar 10, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −2,700 | $42.52 | $115K | 0direct | Mar 10, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −13.0K | $43.17 | $560K | 2,700direct | Mar 10, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −6,805 | $42.51 | $289K | 1.1Mdirect | Mar 10, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −35.0K | $43.28 | $1.5M | 1.1Mdirect | Mar 10, 2023 | Mar 13, 2023 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −7,241 | $50.01 | $362K | 49.2Kdirect | Mar 1, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −4,046 | $47.12 | $191K | 56.4Kdirect | Feb 24, 2023 | Feb 27, 2023 | Form 4 ↗ |
| Durgam Suresh K.SVP, Chief Medical Officer | Sale | −7,906 | $47.14 | $373K | 23.1Kdirect | Feb 24, 2023 | Feb 27, 2023 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −7,906 | $47.03 | $372K | 0direct | Feb 24, 2023 | Feb 27, 2023 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −7,455 | $47.03 | $351K | 0direct | Feb 24, 2023 | Feb 27, 2023 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −22.6K | $47.03 | $1.1M | 1.1Mdirect | Feb 24, 2023 | Feb 27, 2023 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −635 | $48.93 | $31K | 52.6Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −123 | $47.32 | $6K | 53.2Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −3,140 | $46.61 | $146K | 53.3Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Durgam Suresh K.SVP, Chief Medical Officer | Sale | −75 | $49.60 | $4K | 23.1Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Durgam Suresh K.SVP, Chief Medical Officer | Sale | −806 | $48.63 | $39K | 23.2Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Durgam Suresh K.SVP, Chief Medical Officer | Sale | −800 | $47.20 | $38K | 24.0Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Durgam Suresh K.SVP, Chief Medical Officer | Sale | −6,673 | $46.55 | $311K | 24.8Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −100 | $49.60 | $5K | 0direct | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −1,100 | $48.68 | $54K | 100direct | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −643 | $47.23 | $30K | 1,200direct | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −9,296 | $46.56 | $433K | 1,843direct | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −94 | $49.60 | $5K | 0direct | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −900 | $48.72 | $44K | 94direct | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −800 | $47.32 | $38K | 994direct | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −8,649 | $46.54 | $403K | 1,794direct | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −251 | $49.60 | $12K | 1.1Mdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −2,502 | $48.70 | $122K | 1.1Mdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −2,200 | $47.35 | $104K | 1.1Mdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −22.9K | $46.54 | $1.1M | 1.1Mdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −1,689 | $50.59 | $85K | 0direct | Feb 17, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −52.3K | $49.81 | $2.6M | 1,689direct | Feb 17, 2023 | Feb 22, 2023 | Form 4 ↗ |
| MARCUS JOEL SDirector | Sale | −5,000 | $50.82 | $254K | 29.2Kdirect | Dec 19, 2022 | Dec 21, 2022 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −33.1K | $55.00 | $1.8M | 1.1Mdirect | Dec 13, 2022 | Dec 15, 2022 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −22.8K | $53.48 | $1.2M | 0direct | Dec 1, 2022 | Dec 2, 2022 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −27.2K | $53.94 | $1.5M | 22.8Kdirect | Dec 1, 2022 | Dec 2, 2022 | Form 4 ↗ |
| MARCUS JOEL SDirector | Sale | −5,000 | $52.11 | $261K | 34.2Kdirect | Nov 7, 2022 | Nov 8, 2022 | Form 4 ↗ |
| MARCUS JOEL SDirector | Sale | −5,000 | $52.49 | $262K | 39.2Kdirect | Nov 7, 2022 | Nov 8, 2022 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −33.3K | $45.39 | $1.5M | 0direct | Sep 21, 2022 | Sep 23, 2022 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −31.9K | $45.88 | $1.5M | 33.3Kdirect | Sep 21, 2022 | Sep 23, 2022 | Form 4 ↗ |
| VAN NOSTRAND ROBERT LDirector | Sale | −1,500 | $56.80 | $85K | 9,043direct | Aug 11, 2022 | Aug 12, 2022 | Form 4 ↗ |
| VAN NOSTRAND ROBERT LDirector | Sale | −28.5K | $57.15 | $1.6M | 10.5Kdirect | Aug 11, 2022 | Aug 12, 2022 | Form 4 ↗ |
| MARCUS JOEL SDirector | Sale | −10.0K | $59.22 | $592K | 44.2Kdirect | Aug 11, 2022 | Aug 12, 2022 | Form 4 ↗ |
| MARCUS JOEL SDirector | Sale | −10.0K | $55.00 | $550K | 54.2Kdirect | May 12, 2022 | May 13, 2022 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −14.9K | $65.14 | $970K | 45.3Kdirect | Apr 8, 2022 | Apr 8, 2022 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −54.0K | $64.42 | $3.5M | 60.2Kdirect | Apr 8, 2022 | Apr 8, 2022 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −17.5K | $63.55 | $1.1M | 114.2Kdirect | Apr 8, 2022 | Apr 8, 2022 | Form 4 ↗ |
| RIGGS RORY BDirector | Sale | −15.7K | $61.35 | $965K | 0indirect | Mar 18, 2022 | Mar 18, 2022 | Form 4 ↗ |
| RIGGS RORY BDirector | Sale | −4,901 | $60.63 | $297K | 15.7Kindirect | Mar 18, 2022 | Mar 18, 2022 | Form 4 ↗ |
| RIGGS RORY BDirector | Sale | −114.9K | $60.41 | $6.9M | 20.6Kindirect | Mar 17, 2022 | Mar 18, 2022 | Form 4 ↗ |
| RIGGS RORY BDirector | Sale | −26.6K | $59.99 | $1.6M | 135.5Kindirect | Mar 17, 2022 | Mar 18, 2022 | Form 4 ↗ |
| RIGGS RORY BDirector | Sale | −43.8K | $59.53 | $2.6M | 162.1Kindirect | Mar 16, 2022 | Mar 18, 2022 | Form 4 ↗ |
| RIGGS RORY BDirector | Sale | −20.7K | $58.72 | $1.2M | 206.0Kindirect | Mar 16, 2022 | Mar 18, 2022 | Form 4 ↗ |
| MARCUS JOEL SDirector | Sale | −10.0K | $52.89 | $529K | 29.0Kindirect | Mar 8, 2022 | Mar 9, 2022 | Form 4 ↗ |
| MARCUS JOEL SDirector | Sale | −5,000 | $52.25 | $261K | 39.0Kindirect | Mar 8, 2022 | Mar 9, 2022 | Form 4 ↗ |
| MARCUS JOEL SDirector | Sale | −5,000 | $54.52 | $273K | 44.0Kindirect | Mar 7, 2022 | Mar 9, 2022 | Form 4 ↗ |
| Durgam Suresh K.Chief Medical Officer | Sale | −3,860 | $55.52 | $214K | 23.1Kdirect | Mar 4, 2022 | Mar 4, 2022 | Form 4 ↗ |
| Durgam Suresh K.Chief Medical Officer | Sale | −4,177 | $56.98 | $238K | 27.0Kdirect | Mar 2, 2022 | Mar 4, 2022 | Form 4 ↗ |
| Durgam Suresh K.Chief Medical Officer | Sale | −681 | $51.33 | $35K | 31.1Kdirect | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Durgam Suresh K.Chief Medical Officer | Sale | −2,162 | $52.13 | $113K | 31.8Kdirect | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Durgam Suresh K.Chief Medical Officer | Sale | −1,203 | $53.04 | $64K | 34.0Kdirect | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −1,371 | $51.33 | $70K | 45.3Kdirect | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −3,875 | $52.03 | $202K | 46.7Kdirect | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −2,660 | $52.94 | $141K | 50.6Kdirect | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −4,188 | $51.62 | $216K | 0direct | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −3,718 | $52.38 | $195K | 4,188direct | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −100 | $50.94 | $5K | 0direct | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −3,983 | $51.64 | $206K | 100direct | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −3,371 | $52.38 | $177K | 4,083direct | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −100 | $50.92 | $5K | 1.1Mdirect | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −11.2K | $51.61 | $580K | 1.1Mdirect | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −11.2K | $52.35 | $589K | 1.1Mdirect | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Durgam Suresh K.Chief Medical Officer | Sale | −1,357 | $54.80 | $74K | 27.3Kdirect | Feb 22, 2022 | Feb 23, 2022 | Form 4 ↗ |
| Durgam Suresh K.Chief Medical Officer | Sale | −2,820 | $55.53 | $157K | 28.6Kdirect | Feb 22, 2022 | Feb 23, 2022 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −4,607 | $54.84 | $253K | 45.3Kdirect | Feb 22, 2022 | Feb 23, 2022 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −6,532 | $55.60 | $363K | 49.9Kdirect | Feb 22, 2022 | Feb 23, 2022 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −4,550 | $54.98 | $250K | 0direct | Feb 22, 2022 | Feb 23, 2022 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −6,589 | $55.69 | $367K | 4,550direct | Feb 22, 2022 | Feb 23, 2022 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −4,627 | $54.99 | $254K | 0direct | Feb 22, 2022 | Feb 23, 2022 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −5,816 | $55.72 | $324K | 4,627direct | Feb 22, 2022 | Feb 23, 2022 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −12.7K | $54.98 | $696K | 1.1Mdirect | Feb 22, 2022 | Feb 23, 2022 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −15.2K | $55.73 | $846K | 1.1Mdirect | Feb 22, 2022 | Feb 23, 2022 | Form 4 ↗ |
| Durgam Suresh K.Chief Medical Officer | Sale | −6,223 | $42.03 | $262K | 23.1Kdirect | Jan 18, 2022 | Jan 20, 2022 | Form 4 ↗ |
| Durgam Suresh K.Chief Medical Officer | Sale | −500 | $39.83 | $20K | 29.3Kdirect | Jan 10, 2022 | Jan 11, 2022 | Form 4 ↗ |
| Durgam Suresh K.Chief Medical Officer | Sale | −4,850 | $40.63 | $197K | 29.8Kdirect | Jan 10, 2022 | Jan 11, 2022 | Form 4 ↗ |
| Durgam Suresh K.Chief Medical Officer | Sale | −1,520 | $41.48 | $63K | 34.7Kdirect | Jan 10, 2022 | Jan 11, 2022 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −4,252 | $40.09 | $170K | 45.3Kdirect | Jan 10, 2022 | Jan 11, 2022 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −13.9K | $40.80 | $569K | 49.6Kdirect | Jan 10, 2022 | Jan 11, 2022 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −2,761 | $41.74 | $115K | 63.5Kdirect | Jan 10, 2022 | Jan 11, 2022 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −4,380 | $40.12 | $176K | 0direct | Jan 10, 2022 | Jan 11, 2022 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −12.8K | $40.81 | $521K | 4,380direct | Jan 10, 2022 | Jan 11, 2022 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −2,504 | $41.74 | $105K | 17.1Kdirect | Jan 10, 2022 | Jan 11, 2022 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −4,100 | $40.07 | $164K | 0direct | Jan 10, 2022 | Jan 11, 2022 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −12.4K | $40.77 | $507K | 4,100direct | Jan 10, 2022 | Jan 11, 2022 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −3,105 | $41.61 | $129K | 16.5Kdirect | Jan 10, 2022 | Jan 11, 2022 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −8,954 | $40.10 | $359K | 1.1Mdirect | Jan 10, 2022 | Jan 11, 2022 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −27.1K | $40.80 | $1.1M | 1.1Mdirect | Jan 10, 2022 | Jan 11, 2022 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −5,804 | $41.72 | $242K | 1.1Mdirect | Jan 10, 2022 | Jan 11, 2022 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −4,344 | $44.87 | $195K | 0direct | Dec 21, 2021 | Dec 23, 2021 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −8,690 | $45.74 | $397K | 4,344direct | Dec 21, 2021 | Dec 23, 2021 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −36.4K | $46.87 | $1.7M | 13.0Kdirect | Dec 21, 2021 | Dec 23, 2021 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −104.8K | $47.84 | $5.0M | 49.5Kdirect | Dec 21, 2021 | Dec 23, 2021 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −22.6K | $48.62 | $1.1M | 154.2Kdirect | Dec 21, 2021 | Dec 23, 2021 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −600 | $44.28 | $27K | 0direct | Dec 21, 2021 | Dec 23, 2021 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −3,800 | $44.95 | $171K | 600direct | Dec 21, 2021 | Dec 23, 2021 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −9,200 | $45.81 | $421K | 4,400direct | Dec 21, 2021 | Dec 23, 2021 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −35.1K | $46.91 | $1.6M | 13.6Kdirect | Dec 21, 2021 | Dec 23, 2021 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −100.8K | $47.84 | $4.8M | 48.7Kdirect | Dec 21, 2021 | Dec 23, 2021 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −25.5K | $48.67 | $1.2M | 149.5Kdirect | Dec 21, 2021 | Dec 23, 2021 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −500 | $38.88 | $19K | 45.3Kdirect | Oct 18, 2021 | Oct 19, 2021 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −1,958 | $39.44 | $77K | 45.8Kdirect | Oct 18, 2021 | Oct 19, 2021 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −4,288 | $40.77 | $175K | 47.8Kdirect | Oct 18, 2021 | Oct 19, 2021 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −6,702 | $41.49 | $278K | 52.1Kdirect | Oct 18, 2021 | Oct 19, 2021 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −8,192 | $40.00 | $328K | 1.1Mdirect | Oct 18, 2021 | Oct 18, 2021 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −40.4K | $40.00 | $1.6M | 1.1Mdirect | Oct 15, 2021 | Oct 18, 2021 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −1,416 | $40.00 | $57K | 1.1Mdirect | Oct 14, 2021 | Oct 18, 2021 | Form 4 ↗ |
| MARCUS JOEL SDirector | Sale | −18.3K | $42.27 | $773K | 49.0Kindirect | Jun 14, 2021 | Jun 15, 2021 | Form 4 ↗ |
| Alafi Christopher DDirector | Sale | −38.8K | $40.12 | $1.6M | 95.0Kindirect | May 28, 2021 | May 28, 2021 | Form 4 ↗ |
| Alafi Christopher DDirector | Sale | −8,482 | $40.01 | $339K | 133.8Kindirect | May 27, 2021 | May 28, 2021 | Form 4 ↗ |
| Alafi Christopher DDirector | Sale | −26.6K | $40.47 | $1.1M | 142.3Kindirect | May 24, 2021 | May 25, 2021 | Form 4 ↗ |
| Alafi Christopher DDirector | Sale | −1,100 | $40.00 | $44K | 168.9Kindirect | May 21, 2021 | May 25, 2021 | Form 4 ↗ |
| MARCUS JOEL SDirector | Sale | −15.3K | $34.93 | $533K | 72.3Kindirect | Mar 2, 2021 | Mar 4, 2021 | Form 4 ↗ |
| Durgam Suresh K.Chief Medical Officer | Sale | −200 | $38.87 | $8K | 23.1Kdirect | Feb 19, 2021 | Feb 22, 2021 | Form 4 ↗ |
| Durgam Suresh K.Chief Medical Officer | Sale | −2,534 | $39.28 | $100K | 23.3Kdirect | Feb 19, 2021 | Feb 22, 2021 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −600 | $38.90 | $23K | 45.3Kdirect | Feb 19, 2021 | Feb 22, 2021 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −4,584 | $39.26 | $180K | 45.9Kdirect | Feb 19, 2021 | Feb 22, 2021 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −1,200 | $38.91 | $47K | 0direct | Feb 19, 2021 | Feb 22, 2021 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −9,242 | $39.27 | $363K | 1,200direct | Feb 19, 2021 | Feb 22, 2021 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −1,100 | $38.91 | $43K | 0direct | Feb 19, 2021 | Feb 22, 2021 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −10.0K | $39.28 | $394K | 1,100direct | Feb 19, 2021 | Feb 22, 2021 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −3,100 | $38.91 | $121K | 1.1Mdirect | Feb 19, 2021 | Feb 22, 2021 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −24.7K | $39.27 | $972K | 1.1Mdirect | Feb 19, 2021 | Feb 22, 2021 | Form 4 ↗ |
| Durgam Suresh K.Chief Medical Officer | Sale | −100 | $31.60 | $3K | 17.5Kdirect | Jan 11, 2021 | Jan 12, 2021 | Form 4 ↗ |
| Durgam Suresh K.Chief Medical Officer | Sale | −4,267 | $32.13 | $137K | 17.6Kdirect | Jan 11, 2021 | Jan 12, 2021 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −9,684 | $32.02 | $310K | 39.4Kdirect | Jan 11, 2021 | Jan 12, 2021 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −2,376 | $31.64 | $75K | 0direct | Jan 11, 2021 | Jan 12, 2021 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −17.3K | $32.07 | $554K | 2,376direct | Jan 11, 2021 | Jan 12, 2021 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −1,936 | $31.65 | $61K | 0direct | Jan 11, 2021 | Jan 12, 2021 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −17.7K | $32.07 | $568K | 1,936direct | Jan 11, 2021 | Jan 12, 2021 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −4,585 | $31.64 | $145K | 1.1Mdirect | Jan 11, 2021 | Jan 12, 2021 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −37.3K | $32.06 | $1.2M | 1.1Mdirect | Jan 11, 2021 | Jan 12, 2021 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −3,100 | $30.94 | $96K | 350direct | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −12.7K | $31.40 | $399K | 3,450direct | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −3,174 | $30.94 | $98K | 0direct | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −13.0K | $31.39 | $408K | 3,174direct | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −2,800 | $30.94 | $87K | 1.1Mdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −11.2K | $31.39 | $352K | 1.1Mdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −6,428 | $30.94 | $199K | 1.1Mdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −27.9K | $31.39 | $876K | 1.2Mdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −3,761 | $27.95 | $105K | 0direct | Nov 17, 2020 | Nov 19, 2020 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −75.7K | $27.60 | $2.1M | 3,761direct | Nov 17, 2020 | Nov 19, 2020 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −28.0K | $25.41 | $712K | 0direct | Nov 11, 2020 | Nov 13, 2020 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −19.1K | $26.91 | $515K | 1.1Mdirect | Nov 10, 2020 | Nov 12, 2020 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −30.9K | $25.99 | $802K | 1.1Mdirect | Nov 10, 2020 | Nov 12, 2020 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −50.0K | $25.00 | $1.3M | 1.2Mdirect | Nov 4, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Neumann MarkEVP, Chief Commercial Officer | Sale | −6,792 | $26.80 | $182K | 28.1Kdirect | Oct 16, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Alafi Christopher DDirector | Purchase | +49.5K | $29.60 | $1.5M | 4.7Mindirect | Sep 14, 2020 | Sep 14, 2020 | Form 4 ↗ |
| Alafi Christopher DDirector | Purchase | +21.0K | $28.08 | $590K | 4.7Mindirect | Sep 11, 2020 | Sep 11, 2020 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −42.0K | $31.14 | $1.3M | 8,034direct | Sep 9, 2020 | Sep 11, 2020 | Form 4 ↗ |
| MARCUS JOEL SDirector | Sale | −9,602 | $20.04 | $192K | 39.1Kindirect | May 14, 2020 | May 15, 2020 | Form 4 ↗ |
| MARCUS JOEL SDirector | Sale | −7,297 | $20.63 | $151K | 14.4Kdirect | May 13, 2020 | May 13, 2020 | Form 4 ↗ |
| MARCUS JOEL SDirector | Sale | −50.0K | $19.95 | $998K | 48.7Kindirect | May 11, 2020 | May 13, 2020 | Form 4 ↗ |
| LERNER RICHARD ADirector | Sale | −3,500 | $20.50 | $72K | 93.8Kindirect | May 11, 2020 | May 13, 2020 | Form 4 ↗ |
| Satlin AndrewEVP and Chief Medical Officer | Sale | −11.6K | $26.16 | $303K | 11.3Kdirect | Jan 9, 2020 | Jan 10, 2020 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −41.9K | $26.16 | $1.1M | 1.2Mdirect | Jan 9, 2020 | Jan 10, 2020 | Form 4 ↗ |
| Halstead MichaelEVP and General Counsel | Sale | −19.6K | $26.16 | $514K | 191direct | Jan 9, 2020 | Jan 10, 2020 | Form 4 ↗ |
| Hineline Lawrence J.SVP of Finance CFO | Sale | −19.6K | $26.16 | $514K | 18.8Kdirect | Jan 9, 2020 | Jan 10, 2020 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −37.7K | $30.39 | $1.1M | 1.1Mdirect | Jan 6, 2020 | Jan 8, 2020 | Form 4 ↗ |
| Mates SharonChairman, President & CEO · Director | Sale | −7,939 | $29.78 | $236K | 1.2Mdirect | Jan 6, 2020 | Jan 8, 2020 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →